Metraipolis › archive › dc_94b10daafe10

Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab — Europe PMC PMID:41827739

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41827739
DOI
10.3390/cancers18050805
License (as archived)
solo-consultazione
Archived
2026-11-05T10:05:03.052Z
SHA-256 of the archived text
e6bad7f0c74e1f794367f698aa13530dd4cbc872e15df70856b9d4dbff35bfe6
Stable URL of this page
https://metraipolis.com/documento/dc_94b10daafe10

How to cite

Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab — Europe PMC PMID:41827739 — Europe PMC (en), https://europepmc.org/article/MED/41827739 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_94b10daafe10 (Metraipolis archive dc_94b10daafe10, sha256 e6bad7f0c74e1f794367f698aa13530dd4cbc872e15df70856b9d4dbff35bfe6)
BibTeX
@misc{dc94b10daafe10,
  title = {Real-World Outcomes of Primary Versus Interval Debulking Surgery in a Multicenter Cohort of Advanced Ovarian Cancer Patients Treated with Bevacizumab — Europe PMC PMID:41827739},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41827739},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_94b10daafe10; sha256 e6bad7f0c74e1f794367f698aa13530dd4cbc872e15df70856b9d4dbff35bfe6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41827739. Agents can read the archived copy with the MCP tool read_document.